News
Stockhead on MSN17m
Health Check: Snore-buster Resmed says miracle diet drugs and tariffs no threat to growthAfter reporting robust results, Resmed reckons it won't be subject to US tariffs while the growth of anti-obesity drugs will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback